Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes
Many cell types express the p35 chain, while the p40 subunit is expressed principally by activated macrophages and B cells. 2 The heterodimer, p70 or p75, is the biologically active IL-12. 13 IL12B is a candidate for IDDM18, as linkage disequilibrium is confined to a 30 kb region on chromosome 5, in...
Saved in:
Published in: | Journal of medical genetics Vol. 41; no. 4; p. e39 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
BMJ Publishing Group Ltd
01-04-2004
BMJ Publishing Group LTD BMJ Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Many cell types express the p35 chain, while the p40 subunit is expressed principally by activated macrophages and B cells. 2 The heterodimer, p70 or p75, is the biologically active IL-12. 13 IL12B is a candidate for IDDM18, as linkage disequilibrium is confined to a 30 kb region on chromosome 5, in which IL12B is the only known gene. 4 Several polymorphisms have been identified in IL12B, 2, 14 of which the A allele of a 3[variant prime]UTR (untranslated region) single nucleotide polymorphism (C1159A SNP) showed strong linkage disequilibrium with the T1DM susceptibility locus in Australian and British diabetes families. 4 Interestingly, evidence for functional significance of the 3[variant prime]UTR polymorphism was found by investigating Epstein-Barr virus (EBV) transformed cell lines. 4 A cell line with the genotype A/A showed significantly higher mRNA expression level than a C/C cell line. 4 In a recently undertaken Scandinavian T1DM genome scan no evidence for linkage to this region on chromosome 5 was demonstrated. 15 Confirmation of the significance of the IL12B 3[variant prime]UTR polymorphism in T1DM in other populations is important. [...]both the genetic and the functional data conflict with the original findings, and do not support the IL12B locus as a risk locus for T1DM. |
---|---|
Bibliography: | Correspondence to:
Dr F Pociot
Flemming Pociot, Steno Diabetes Centre, 2 Niels Steensensvej, DK-2820 Gentofte, Denmark; fpoc@steno.dk href:jmedgenet-41-e39.pdf ark:/67375/NVC-45J5T2QL-T istex:FFDE67B6098645B792F2F0C7F48D46380A0D90C4 PMID:15060115 local:0410e39 SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Correspondence-1 |
ISSN: | 0022-2593 1468-6244 1468-6244 |
DOI: | 10.1136/jmg.2003.010454 |